ALZN logo

Alzamend Neuro (ALZN) Cash From Operations

Annual CFO

-$8.27 M
+$653.20 K+7.32%

April 30, 2024


Summary


Performance

ALZN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALZNcash flowmetrics:

Quarterly CFO

-$3.40 M
-$2.34 M-222.07%

October 31, 2024


Summary


Performance

ALZN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALZNcash flowmetrics:

TTM CFO

-$7.91 M
-$1.89 M-31.30%

October 31, 2024


Summary


Performance

ALZN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALZNcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ALZN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.3%-222.1%-31.3%
3 y3 years-204.9%-222.1%-31.3%
5 y5 years-691.2%-222.1%-31.3%

ALZN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-204.9%+7.3%-222.1%at low-31.3%+18.3%
5 y5-year-691.2%+7.3%-1557.8%at low-3758.7%+18.3%
alltimeall time-691.2%+7.3%-1557.8%at low-3758.7%+18.3%

Alzamend Neuro Cash From Operations History

DateAnnualQuarterlyTTM
Oct 2024
-
-$3.40 M(+222.1%)
-$7.91 M(+31.3%)
Jul 2024
-
-$1.06 M(-26.0%)
-$6.03 M(-27.1%)
Apr 2024
-$8.27 M(-7.3%)
-$1.43 M(-29.8%)
-$8.27 M(-8.9%)
Jan 2024
-
-$2.03 M(+34.2%)
-$9.08 M(+2.5%)
Oct 2023
-
-$1.51 M(-54.1%)
-$8.85 M(-8.6%)
Jul 2023
-
-$3.30 M(+47.6%)
-$9.68 M(+8.5%)
Apr 2023
-$8.92 M(+34.9%)
-$2.24 M(+23.7%)
-$8.92 M(+8.2%)
Jan 2023
-
-$1.81 M(-22.9%)
-$8.25 M(+0.3%)
Oct 2022
-
-$2.34 M(-7.6%)
-$8.23 M(+3.8%)
Jul 2022
-
-$2.54 M(+62.4%)
-$7.93 M(+19.9%)
DateAnnualQuarterlyTTM
Apr 2022
-$6.61 M(+143.9%)
-$1.56 M(-12.4%)
-$6.61 M(+4.8%)
Jan 2022
-
-$1.78 M(-12.9%)
-$6.31 M(+18.3%)
Oct 2021
-
-$2.05 M(+67.4%)
-$5.33 M(+43.0%)
Jul 2021
-
-$1.22 M(-2.8%)
-$3.73 M(+37.5%)
Apr 2021
-$2.71 M(+15.6%)
-$1.26 M(+56.0%)
-$2.71 M(+86.5%)
Jan 2021
-
-$806.10 K(+82.0%)
-$1.45 M(+124.4%)
Oct 2020
-
-$442.90 K(+115.9%)
-$648.00 K(+215.9%)
Jul 2020
-
-$205.10 K
-$205.10 K
Apr 2020
-$2.35 M(+124.4%)
-
-
Apr 2019
-$1.05 M
-
-

FAQ

  • What is Alzamend Neuro annual cash flow from operations?
  • What is the all time high annual CFO for Alzamend Neuro?
  • What is Alzamend Neuro annual CFO year-on-year change?
  • What is Alzamend Neuro quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Alzamend Neuro?
  • What is Alzamend Neuro quarterly CFO year-on-year change?
  • What is Alzamend Neuro TTM cash flow from operations?
  • What is the all time high TTM CFO for Alzamend Neuro?
  • What is Alzamend Neuro TTM CFO year-on-year change?

What is Alzamend Neuro annual cash flow from operations?

The current annual CFO of ALZN is -$8.27 M

What is the all time high annual CFO for Alzamend Neuro?

Alzamend Neuro all-time high annual cash flow from operations is -$1.05 M

What is Alzamend Neuro annual CFO year-on-year change?

Over the past year, ALZN annual cash flow from operations has changed by +$653.20 K (+7.32%)

What is Alzamend Neuro quarterly cash flow from operations?

The current quarterly CFO of ALZN is -$3.40 M

What is the all time high quarterly CFO for Alzamend Neuro?

Alzamend Neuro all-time high quarterly cash flow from operations is -$205.10 K

What is Alzamend Neuro quarterly CFO year-on-year change?

Over the past year, ALZN quarterly cash flow from operations has changed by -$2.34 M (-222.07%)

What is Alzamend Neuro TTM cash flow from operations?

The current TTM CFO of ALZN is -$7.91 M

What is the all time high TTM CFO for Alzamend Neuro?

Alzamend Neuro all-time high TTM cash flow from operations is -$205.10 K

What is Alzamend Neuro TTM CFO year-on-year change?

Over the past year, ALZN TTM cash flow from operations has changed by -$1.89 M (-31.30%)